drugset / Trial / NCT00838812

Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate

NCT00838812

Phase 3 Completed 154 enrolled Igefarma Laboratorios S.A.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety and efficacy of association between tretinoin and clindamycin phosphate on the treatment of acne vulgaris mild and moderate.

Timeline

Start
2009-03
Primary completion
2010-01
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Clindamycin Unknown 1.2 % Topical
Subject Tretinoin Small molecule 0.025 % Topical

Indications